Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis. 1979

G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
January 1980, The Journal of antimicrobial chemotherapy,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
January 1993, Drugs under experimental and clinical research,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
June 1974, Antimicrobial agents and chemotherapy,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
January 2009, International journal of clinical pharmacology and therapeutics,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
October 2012, Clinical pharmacokinetics,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
August 1979, European journal of clinical pharmacology,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
January 1982, European journal of drug metabolism and pharmacokinetics,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
July 2014, Epilepsy research,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
December 1977, Antimicrobial agents and chemotherapy,
G Gartenberg, and B R Meyers, and S Z Hirschmann, and E Srulevitch
March 2024, British journal of clinical pharmacology,
Copied contents to your clipboard!